Starpharma Holdings Limited (SPHRF)

USD 0.07

(0.0%)

Long Term Debt Summary of Starpharma Holdings Limited

  • Starpharma Holdings Limited's latest annual long term debt in 2024 was 1.95 Million AUD , down 0.0% from previous year.
  • Starpharma Holdings Limited's latest quarterly long term debt in 2024 FY was - AUD , down -100.0% from previous quarter.
  • Starpharma Holdings Limited reported annual long term debt of 2.75 Million AUD in 2023, down -63.3% from previous year.
  • Starpharma Holdings Limited reported annual long term debt of 7.49 Million AUD in 2022, up 1477.68% from previous year.
  • Starpharma Holdings Limited reported quarterly long term debt of 1.95 Million AUD for 2024 Q4, down 0.0% from previous quarter.
  • Starpharma Holdings Limited reported quarterly long term debt of - AUD for 2024 FY, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Starpharma Holdings Limited (2024 - 1998)

Historical Annual Long Term Debt of Starpharma Holdings Limited (2024 - 1998)

Year Long Term Debt Long Term Debt Growth
2024 1.95 Million AUD 0.0%
2023 2.75 Million AUD -63.3%
2022 7.49 Million AUD 1477.68%
2021 475 Thousand AUD -51.03%
2020 970 Thousand AUD 0.0%
2019 - AUD -100.0%
2018 23 Thousand AUD -51.06%
2017 47 Thousand AUD 0.0%
2016 - AUD -100.0%
2015 18 Thousand AUD -62.5%
2014 48 Thousand AUD -36.0%
2013 75 Thousand AUD -25.0%
2012 100 Thousand AUD 488.24%
2011 17 Thousand AUD 0.0%
2010 - AUD -100.0%
2009 160 Thousand AUD -45.39%
2008 293 Thousand AUD 12.63%
2007 260.14 Thousand AUD -17.52%
2006 315.41 Thousand AUD 295.5%
2005 79.75 Thousand AUD -44.43%
2004 143.51 Thousand AUD -29.48%
2003 203.52 Thousand AUD 0.0%
2002 - AUD 0.0%
2001 - AUD 0.0%
2000 - AUD 0.0%
1999 - AUD 0.0%
1998 - AUD 0.0%

Peer Long Term Debt Comparison of Starpharma Holdings Limited

Name Long Term Debt Long Term Debt Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 1.75 Million USD -11.48%
Neon Bloom, Inc. - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -2346.25%
Regen BioPharma, Inc. 149.61 Thousand USD -1208.033%
Evofem Biosciences, Inc. 8000.00 USD -24362.5%
BioStem Technologies, Inc. 265.63 Thousand USD -636.725%
Skye Bioscience, Inc. 171.23 Thousand USD -1042.907%
ProtoKinetix, Incorporated - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.983%
Northwest Biotherapeutics, Inc. 20.31 Million USD 90.365%
Capstone Therapeutics Corp. 8.26 Million USD 76.319%
Acro Biomedical Co., Ltd. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 90.64%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -3237.199%
Mesoblast Limited 100.29 Million USD 98.049%
Marizyme, Inc. 667.12 Thousand USD -193.347%
Genus plc 228.2 Million USD 99.142%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 98.822%
Therapeutic Solutions International, Inc. 5512.00 USD -35404.354%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 11.448%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -39.493%
IMV Inc. 27.39 Million USD 92.857%
AXIM Biotechnologies, Inc. 5.42 Million USD 63.936%
MultiCell Technologies, Inc. 36.43 USD -5371846.198%
ONE Bio Corp. 592.19 Thousand USD -230.464%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 96.481%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 12.084%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -59.318%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -252.873%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -7635.484%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD -3.083%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -507.764%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -1204.667%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -1091.803%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 87.254%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -43818.312%
Genscript Biotech Corporation 287.12 Million USD 99.318%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -1449.461%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -753.501%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -752.014%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -183828.571%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -1208.033%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -1287.943%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 74.974%
SYBLEU INC 300 Thousand USD -552.333%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -430.282%
International Stem Cell Corporation 445 Thousand USD -339.775%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 75.988%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -328.228%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -68.562%
PureTech Health plc 18.25 Million USD 89.277%
Coeptis Therapeutics, Inc. 150 Thousand USD -1204.667%
IXICO plc 275 Thousand USD -611.636%
IntelGenx Technologies Corp. 11.83 Million USD 83.47%
Gelesis Holdings, Inc. 26.3 Million USD 92.561%
CSL Limited 11.23 Billion USD 99.983%
Cellectis S.A. 36.21 Million USD 94.596%